Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experienceLuca Diamanti, Enrico Marchioni, Eugenia Rota et al.|Neurological Sciences|2021Cited by 36
2900 Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)Giuseppe Lombardi, Roberta Rudà, Silvia Scoccianti et al.|European Journal of Cancer|2015Cited by 0
Prognostic factors in glioblastoma patients treated with the nitrosourea fotemustine at first relapse after the Stupp regimen: results from the GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)Matteo Santoni, Roberta Rudà, Giuseppe Lombardi et al.|Annals of Oncology|2015Cited by 0